Literature DB >> 19264265

Comorbidity in pediatric bipolar disorder.

Gagan Joshi1, Timothy Wilens.   

Abstract

The growing literature shows the pervasiveness and importance of comorbidity in youth with bipolar disorder (BPD). For instance, up to 90% of youth with BPD have been described to manifest comorbidity with attention-deficit hyperactivity disorder. Multiple anxiety, substance use, and disruptive behavior disorders are the other most commonly reported comorbidities with BPD. Moreover, important recent data highlight the importance of obsessive-compulsive and pervasive developmental illness in the context of BPD. Data suggest that not only special developmental relationships are operant in the context of comorbidity but also that the presence of comorbid disorders with BPD results in a more severe clinical condition. Moreover, the presence of comorbidity has therapeutic implications for the treatment response for both BPD and the associated comorbid disorder. Future longitudinal studies to address the relationship and the impact of comorbid disorders on course and therapeutic response over time are required in youth with BPD.

Entities:  

Mesh:

Year:  2009        PMID: 19264265      PMCID: PMC3757953          DOI: 10.1016/j.chc.2008.12.005

Source DB:  PubMed          Journal:  Child Adolesc Psychiatr Clin N Am        ISSN: 1056-4993


  166 in total

Review 1.  Toward a transactional conceptualization of oppositional defiant disorder: implications for assessment and treatment.

Authors:  R W Greene; A E Doyle
Journal:  Clin Child Fam Psychol Rev       Date:  1999-09

2.  Parsing the comorbidity between bipolar disorder and anxiety disorders: a familial risk analysis.

Authors:  Janet Wozniak; Joseph Biederman; Michael C Monuteaux; Jennifer Richards; Stephen V Faraone
Journal:  J Child Adolesc Psychopharmacol       Date:  2002       Impact factor: 2.576

3.  Attention deficit hyperactivity disorder with bipolar disorder in girls: further evidence for a familial subtype?

Authors:  S V Faraone; J Biederman; M C Monuteaux
Journal:  J Affect Disord       Date:  2001-04       Impact factor: 4.839

4.  Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder.

Authors:  S L McElroy; L L Altshuler; T Suppes; P E Keck; M A Frye; K D Denicoff; W A Nolen; R W Kupka; G S Leverich; J R Rochussen; A J Rush; R M Post
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

5.  [Cyclothymic obsessive-compulsive disorder. Clinical characteristics of a neglected and under-recognized entity].

Authors:  E G Hantouche; C Demonfaucon; J Angst; G Perugi; J F Allilaire; H S Akiskal
Journal:  Presse Med       Date:  2002-04-13       Impact factor: 1.228

6.  Is bipolar disorder specifically associated with panic disorder in youths?

Authors:  Boris Birmaher; Adam Kennah; David Brent; Mary Ehmann; Jeff Bridge; David Axelson
Journal:  J Clin Psychiatry       Date:  2002-05       Impact factor: 4.384

7.  Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs.

Authors:  Atilla Turgay; Carin Binder; Richard Snyder; Sandra Fisman
Journal:  Pediatrics       Date:  2002-09       Impact factor: 7.124

8.  Bipolar-panic comorbidity in the general population: prevalence and associated morbidity.

Authors:  Renee D Goodwin; Christina W Hoven
Journal:  J Affect Disord       Date:  2002-06       Impact factor: 4.839

9.  Risperidone in children with autism and serious behavioral problems.

Authors:  James T McCracken; James McGough; Bhavik Shah; Pegeen Cronin; Daniel Hong; Michael G Aman; L Eugene Arnold; Ronald Lindsay; Patricia Nash; Jill Hollway; Christopher J McDougle; David Posey; Naomi Swiezy; Arlene Kohn; Lawrence Scahill; Andres Martin; Kathleen Koenig; Fred Volkmar; Deirdre Carroll; Allison Lancor; Elaine Tierney; Jaswinder Ghuman; Nilda M Gonzalez; Marco Grados; Benedetto Vitiello; Louise Ritz; Mark Davies; James Robinson; Don McMahon
Journal:  N Engl J Med       Date:  2002-08-01       Impact factor: 91.245

10.  Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence.

Authors:  Michael G Aman; Goedele De Smedt; Albert Derivan; Ben Lyons; Robert L Findling
Journal:  Am J Psychiatry       Date:  2002-08       Impact factor: 18.112

View more
  12 in total

1.  Using stimulants for attention-deficit/hyperactivity disorder: clinical approaches and challenges.

Authors:  Jonathan R Stevens; Timothy E Wilens; Theodore A Stern
Journal:  Prim Care Companion CNS Disord       Date:  2013-03-28

2.  Anxiety in children with mood disorders: a treatment help or hindrance?

Authors:  Colleen M Cummings; Mary A Fristad
Journal:  J Abnorm Child Psychol       Date:  2012-04

3.  Comorbid anxiety in children and adolescents with bipolar spectrum disorders: prevalence and clinical correlates.

Authors:  Regina Sala; David A Axelson; Josefina Castro-Fornieles; Tina R Goldstein; Wonho Ha; Fangzi Liao; Mary Kay Gill; Satish Iyengar; Michael A Strober; Benjamin I Goldstein; Shirley Yen; Heather Hower; Jeffrey Hunt; Neal D Ryan; Daniel Dickstein; Martin B Keller; Boris Birmaher
Journal:  J Clin Psychiatry       Date:  2010-09-07       Impact factor: 4.384

4.  Emotional face identification in youths with primary bipolar disorder or primary attention-deficit/hyperactivity disorder.

Authors:  Karen E Seymour; Matthew F Pescosolido; Brooke L Reidy; Thania Galvan; Kerri L Kim; Matthew Young; Daniel P Dickstein
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-05       Impact factor: 8.829

5.  Factors associated with the persistence and onset of new anxiety disorders in youth with bipolar spectrum disorders.

Authors:  Regina Sala; David A Axelson; Josefina Castro-Fornieles; Tina R Goldstein; Benjamin I Goldstein; Wonho Ha; Fangzi Liao; Mary Kay Gill; Satish Iyengar; Michael A Strober; Shirley Yen; Heather Hower; Jeffrey I Hunt; Daniel P Dickstein; Neal D Ryan; Martin B Keller; Boris Birmaher
Journal:  J Clin Psychiatry       Date:  2011-12-13       Impact factor: 4.384

6.  Decreased anterior cingulate activation in a motor task in youths with bipolar disorder.

Authors:  Jace B King; Jeffrey S Anderson; Deborah A Yurgelun-Todd; Punitha Subramaniam; Marie R Ehrler; Melissa P Lopez-Larson
Journal:  J Child Psychol Psychiatry       Date:  2018-02-16       Impact factor: 8.982

7.  Effects of comorbid anxiety disorders on the longitudinal course of pediatric bipolar disorders.

Authors:  Regina Sala; Michael A Strober; David A Axelson; Mary Kay Gill; Josefina Castro-Fornieles; Tina R Goldstein; Benjamin I Goldstein; Wonho Ha; Fangzi Liao; Satish Iyengar; Shirley Yen; Heather Hower; Jeffrey Hunt; Daniel P Dickstein; Neal D Ryan; Martin B Keller; Boris Birmaher
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-10-17       Impact factor: 8.829

8.  Lifetime psychopathology among the offspring of Bipolar I parents.

Authors:  Marcelo C Zappitelli; Isabel A Bordin; John P Hatch; Sheila C Caetano; Giovana Zunta-Soares; Rene L Olvera; Jair C Soares
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 9.  Obsessive-compulsive disorder and its related disorders: a reappraisal of obsessive-compulsive spectrum concepts.

Authors:  Dennis L Murphy; Kiara R Timpano; Michael G Wheaton; Benjamin D Greenberg; Euripedes C Miguel
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

10.  Aripiprazole in the treatment of refractory mood disorders: a case series.

Authors:  Ather Muneer
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-08-12       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.